Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma [9]

Leukemia

Volumn 22, Issue 2, 2008, Pages 441-445

  Heintel, D ^a   Zojer, N ^b   Schreder, M ^b   Strasser Weippl, K ^b   Kainz, B ^a   Vesely, M ^a   Gisslinger, H ^a   Drach, J ^a   Gaiger, A ^a   Jager U ^a   Ludwig, H ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; CREATININE; HEMOGLOBIN; INTERFERON REGULATORY FACTOR 4; MELPHALAN; MESSENGER RNA; PREDNISONE; THALIDOMIDE;

AGED; B LYMPHOCYTE; BONE MARROW BIOPSY; BONE MARROW CELL; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; GENE EXPRESSION; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SURVIVAL TIME; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 39149110926     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404895     Document Type: Letter

References (7)

1. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997; 17: 226-230.
2. Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 2000; 14: 449-456.
3. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006; 7: 773-782.
4. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
5. Heintel D, Kroemer E, Kienle D, Schwarzinger I, Gleiss A, Schwarzmeier J et al. High expression of activation-induced cytidine deaminase (AJD) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004; 18: 756-762.
6. Zojer N, Konigsberg R, Ackermann J, Fritz E, Dallinger S, Kromer E et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 2000; 95 1925-1930.
7. Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000; 95: 2084-2092.